US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kymera Therapeutics, Inc.

85.40

+0.47000.55%

Pre-market: 85.11-0.2900-0.34%09:26 EDT

Volume:690.93K

Turnover:58.44M

Market Cap:6.97B

PE:-23.14

High:85.65

Open:82.78

Low:82.67

Close:84.93

52wk High:103.00

52wk Low:19.45

Shares:81.64M

Float Shares:54.63M

Volume Ratio:0.86

T/O Rate:1.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.6900

EPS(LYR):-3.6900

ROE:-25.78%

ROA:-15.87%

PB:4.41

PE(LYR):-23.14

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix

Kymera Therapeutics Shares up 37.9% After Positive Data for Eczema Drug

THOMSON REUTERS

Sector Update: Health Care Stocks Rise Pre-Bell Monday

MT Newswires Live

Kymera Therapeutics Showcases Advances in Oral Immunology Medicines and Targeted Protein Degradation

Kymera Therapeutics Shares Gain 32% Premarket After Positive Data for Its Eczema Drug

THOMSON REUTERS

Kymera Therapeutics Stock Soars 30%. Why Investors Are Excited About Its Anti-Inflammatory Drug. -- Barrons.com

BRIEF-Kymera Therapeutics Says KT-621 Well-Tolerated With No Serious Adverse Events Reported

Kymera Therapeutics Stock Surges 23% After Positive Data for Eczema Drug

Kymera Therapeutics Reports Positive Phase 1b Results for Oral STAT6 Degrader KT-621 in Atopic Dermatitis

Kymera Therapeutics Inc - Robust Clinical Activity Was Observed Across All Disease Endpoints Measured for KT-621

THOMSON REUTERS

Kymera Therapeutics Announces Positive Results From Broaden Phase 1B Clinical Trial of KT-621, a First-in-Class, Oral Stat6 Degrader, in Patients With Moderate to Severe Atopic Dermatitis

THOMSON REUTERS

Kymera Therapeutics Inc - KT-621 Broaden2 Phase 2B Trial to Severe Ad Ongoing, Data Expected by Mid-2027

THOMSON REUTERS

Kymera Therapeutics Inc - KT-621 Shows 63% Easi Reduction and 40% Peak Pruritus Reduction

THOMSON REUTERS

Kymera Therapeutics Inc - KT-621 Achieves 94% and 98% Stat6 Degradation in Skin and Blood

THOMSON REUTERS

Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025

A Look at Kymera Therapeutics (KYMR) Valuation Following BROADEN2 Phase 2b KT-621 Dosing Milestone

Simply Wall St.

Kymera Therapeutics Is Maintained at Buy by Truist Securities

Kymera Therapeutics (KYMR) Gets a Buy from Truist Financial

Truist Securities Raises Price Target on Kymera Therapeutics to $80 From $68, Maintains Buy Rating

MT Newswires Live

Kymera Therapeutics Launches Phase 2b Trial of Oral STAT6 Degrader KT-621 in Atopic Dermatitis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KYMR/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYMR\",,,,,undefined,":{"symbol":"KYMR","market":"US","secType":"STK","nameCN":"Kymera Therapeutics, Inc.","latestPrice":85.4,"timestamp":1775160000000,"preClose":84.93,"halted":0,"volume":690925,"hourTrading":{"tag":"盘前","latestPrice":85.11,"preClose":85.4,"latestTime":"09:26 EDT","volume":208,"amount":17770.810719999998,"timestamp":1775482002315,"change":-0.29,"changeRate":-0.003396,"amplitude":0.021077},"delay":0,"changeRate":0.0055339691510655695,"floatShares":54626600,"shares":81642394,"eps":-3.69,"marketStatus":"Pre-Mkt","change":0.47,"latestTime":"04-06 09:29:02 EDT","open":82.78,"high":85.65,"low":82.67,"amount":58442312.58925,"amplitude":0.035088,"askPrice":87.7,"askSize":50,"bidPrice":80.62,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.69,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775482200000},"marketStatusCode":1,"adr":0,"listingDate":1597982400000,"exchange":"NASDAQ","adjPreClose":85.4,"preHourTrading":{"tag":"盘前","latestPrice":85.11,"preClose":85.4,"latestTime":"09:26 EDT","volume":208,"amount":17770.810719999998,"timestamp":1775482002315,"change":-0.29,"changeRate":-0.003396,"amplitude":0.021077},"postHourTrading":{"tag":"盘后","latestPrice":85.4,"preClose":85.4,"latestTime":"18:44 EDT","volume":14268,"amount":1218548.4,"timestamp":1775169868746,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8609986351726134,"impliedVol":0.7265,"impliedVolPercentile":0.5582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYMR\",,,,,undefined,":{"symbol":"KYMR","floatShares":54626600,"roa":"-15.87%","roe":"-25.78%","lyrEps":-3.69,"volumeRatio":0.8609986351726134,"shares":81642394,"dividePrice":0,"high":85.65,"amplitude":0.035088,"preClose":84.93,"low":82.67,"week52Low":19.445,"pbRate":"4.41","psRate":"177.81","week52High":103,"institutionHeld":0,"latestPrice":85.4,"committee":0.333333,"eps":-3.69,"divideRate":0,"volume":690925,"delay":0,"ttmEps":-3.69,"open":82.78,"prevYearClose":77.81,"fiveDayClose":80.18,"twentyDayClose":83.52,"sixtyDayClose":73.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYMR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-26","symbol":"KYMR","fiscalQuarterEnding":"2025/12","expectedEps":-0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":-0.97},{"market":"US","date":"2025-11-04","symbol":"KYMR","fiscalQuarterEnding":"2025/09","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-08-11","symbol":"KYMR","fiscalQuarterEnding":"2025/06","expectedEps":-0.83,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2025-05-09","symbol":"KYMR","fiscalQuarterEnding":"2025/03","expectedEps":-0.92,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.82},{"market":"US","date":"2025-02-27","symbol":"KYMR","fiscalQuarterEnding":"2024/12","expectedEps":-0.76,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-0.88}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYMR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3913,"buy":0.5652,"hold":0.0435,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5652,"analysts":23,"updateTime":1767758400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYMR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYMR","date":"2026-04-02","current":-23.143631,"percent":0.203526,"low":-64.746367,"twenty":-22.323196,"median":-13.732985,"eighty":-9.124493,"high":-3.789687,"avg":-18.427507,"sd":13.296248,"marketCap":6933888522},"quantilePoints":[{"date":"2021-04-09","current":-32.866801,"twenty":-64.880396,"median":-46.53986,"eighty":-30.502746,"marketCap":1498496058},{"date":"2021-04-16","current":-37.997324,"twenty":-63.732865,"median":-46.227265,"eighty":-30.547254,"marketCap":1732412010},{"date":"2021-04-23","current":-37.289666,"twenty":-63.473423,"median":-45.761534,"eighty":-30.891255,"marketCap":1700147740},{"date":"2021-04-30","current":-45.023652,"twenty":-62.834798,"median":-44.993452,"eighty":-30.958705,"marketCap":2052763360},{"date":"2021-05-07","current":-41.468437,"twenty":-62.355828,"median":-44.903381,"eighty":-30.96801,"marketCap":1979537312},{"date":"2021-05-14","current":-42.852287,"twenty":-61.86688,"median":-44.476058,"eighty":-31.172727,"marketCap":2045596787},{"date":"2021-05-21","current":-42.117999,"twenty":-61.836945,"median":-43.894478,"eighty":-32.168393,"marketCap":2010544821},{"date":"2021-05-28","current":-45.271672,"twenty":-61.816988,"median":-43.735893,"eighty":-32.577826,"marketCap":2161088521},{"date":"2021-06-04","current":-44.904528,"twenty":-61.609434,"median":-43.980582,"eighty":-32.809006,"marketCap":2143562538},{"date":"2021-06-11","current":-47.587503,"twenty":-61.509649,"median":-44.22865,"eighty":-33.365155,"marketCap":2271637029},{"date":"2021-06-18","current":-44.57504,"twenty":-60.859049,"median":-44.457366,"eighty":-33.549298,"marketCap":2127834092},{"date":"2021-06-25","current":-41.779097,"twenty":-60.63553,"median":-44.248307,"eighty":-33.646073,"marketCap":1994366990},{"date":"2021-07-02","current":-58.674121,"twenty":-60.01287,"median":-44.377347,"eighty":-33.867539,"marketCap":2800867837},{"date":"2021-07-09","current":-54.868569,"twenty":-59.394201,"median":-44.639425,"eighty":-33.945704,"marketCap":2619206021},{"date":"2021-07-16","current":-52.206763,"twenty":-59.039657,"median":-44.866872,"eighty":-34.109477,"marketCap":2492142018},{"date":"2021-07-23","current":-60.462522,"twenty":-59.549606,"median":-44.91059,"eighty":-34.250917,"marketCap":2886238964},{"date":"2021-07-30","current":-62.573252,"twenty":-60.456284,"median":-45.023652,"eighty":-34.30861,"marketCap":2986996747},{"date":"2021-08-06","current":-51.928779,"twenty":-60.974802,"median":-45.464658,"eighty":-34.365027,"marketCap":3033004215},{"date":"2021-08-13","current":-47.068364,"twenty":-60.651495,"median":-45.711642,"eighty":-34.525867,"marketCap":2749121952},{"date":"2021-08-20","current":-46.841487,"twenty":-60.525339,"median":-45.681179,"eighty":-34.643843,"marketCap":2735870715},{"date":"2021-08-27","current":-52.583234,"twenty":-60.456284,"median":-45.761534,"eighty":-34.80179,"marketCap":3071228936},{"date":"2021-09-03","current":-52.39126,"twenty":-60.097568,"median":-46.12249,"eighty":-34.975392,"marketCap":3060016351},{"date":"2021-09-10","current":-58.167912,"twenty":-59.789796,"median":-46.231492,"eighty":-35.068445,"marketCap":3397413224},{"date":"2021-09-17","current":-54.930544,"twenty":-59.674378,"median":-46.53986,"eighty":-35.246583,"marketCap":3208328270},{"date":"2021-09-24","current":-54.537871,"twenty":-59.587037,"median":-46.809695,"eighty":-35.522327,"marketCap":3185393437},{"date":"2021-10-01","current":-52.54833,"twenty":-59.317994,"median":-46.890871,"eighty":-35.686253,"marketCap":3069190284},{"date":"2021-10-08","current":-48.51689,"twenty":-59.054061,"median":-47.083511,"eighty":-35.748479,"marketCap":2833726002},{"date":"2021-10-15","current":-49.91306,"twenty":-58.876157,"median":-47.068364,"eighty":-35.81053,"marketCap":2915272074},{"date":"2021-10-22","current":-48.586699,"twenty":-58.513954,"median":-47.083511,"eighty":-35.888209,"marketCap":2837803305},{"date":"2021-10-29","current":-51.379038,"twenty":-58.231387,"median":-47.634572,"eighty":-36.031291,"marketCap":3000895449},{"date":"2021-11-05","current":-56.66703,"twenty":-57.962548,"median":-47.834805,"eighty":-36.268304,"marketCap":3309751197},{"date":"2021-11-12","current":-40.862951,"twenty":-57.592374,"median":-47.792627,"eighty":-36.643399,"marketCap":3228254889},{"date":"2021-11-19","current":-39.959795,"twenty":-57.394247,"median":-47.611037,"eighty":-37.018397,"marketCap":3156903732},{"date":"2021-11-26","current":-34.950201,"twenty":-57.231083,"median":-47.083511,"eighty":-36.522189,"marketCap":2761135800},{"date":"2021-12-03","current":-34.534359,"twenty":-57.176853,"median":-46.939001,"eighty":-35.85679,"marketCap":2728283469},{"date":"2021-12-10","current":-34.469384,"twenty":-57.023938,"median":-46.854693,"eighty":-35.731094,"marketCap":2723150292},{"date":"2021-12-17","current":-35.067157,"twenty":-56.895652,"median":-46.777903,"eighty":-35.441994,"marketCap":2770375518},{"date":"2021-12-23","current":-40.135228,"twenty":-56.832825,"median":-46.53986,"eighty":-35.508989,"marketCap":3170763309},{"date":"2021-12-31","current":-41.252803,"twenty":-56.832825,"median":-46.231492,"eighty":-35.541476,"marketCap":3259053950},{"date":"2022-01-07","current":-36.100264,"twenty":-56.728112,"median":-46.187032,"eighty":-35.667949,"marketCap":2851993030},{"date":"2022-01-14","current":-26.685346,"twenty":-56.71066,"median":-46.004337,"eighty":-35.425245,"marketCap":2108195711},{"date":"2022-01-21","current":-24.716595,"twenty":-56.675756,"median":-45.799762,"eighty":-35.072355,"marketCap":1952660454},{"date":"2022-01-28","current":-25.002486,"twenty":-56.639106,"median":-45.704713,"eighty":-34.970993,"marketCap":1975246432},{"date":"2022-02-04","current":-25.814677,"twenty":-56.535547,"median":-45.445318,"eighty":-34.855337,"marketCap":2039411142},{"date":"2022-02-11","current":-27.315606,"twenty":-56.458749,"median":-45.224602,"eighty":-34.521364,"marketCap":2157987526},{"date":"2022-02-18","current":-25.210407,"twenty":-56.1271,"median":-44.939951,"eighty":-34.265806,"marketCap":1991672598},{"date":"2022-02-25","current":-20.657659,"twenty":-56.016065,"median":-44.903954,"eighty":-33.945704,"marketCap":2070248565},{"date":"2022-03-04","current":-18.502704,"twenty":-55.854061,"median":-44.772733,"eighty":-33.283828,"marketCap":1854285526},{"date":"2022-03-11","current":-19.812174,"twenty":-55.682188,"median":-44.495341,"eighty":-32.324854,"marketCap":1985516655},{"date":"2022-03-18","current":-22.317695,"twenty":-55.576416,"median":-44.339691,"eighty":-30.931725,"marketCap":2236612438},{"date":"2022-03-25","current":-20.843253,"twenty":-55.509604,"median":-44.227687,"eighty":-29.91279,"marketCap":2088848253},{"date":"2022-04-01","current":-21.477366,"twenty":-55.415713,"median":-43.894478,"eighty":-29.09307,"marketCap":2152397186},{"date":"2022-04-08","current":-18.368664,"twenty":-55.256898,"median":-43.540327,"eighty":-28.991566,"marketCap":1840852418},{"date":"2022-04-14","current":-19.611114,"twenty":-55.165513,"median":-43.260183,"eighty":-28.567245,"marketCap":1965366993},{"date":"2022-04-22","current":-17.46647,"twenty":-55.132037,"median":-42.908771,"eighty":-28.180145,"marketCap":1750437270},{"date":"2022-04-29","current":-16.167875,"twenty":-55.087613,"median":-42.53692,"eighty":-27.835849,"marketCap":1620295970},{"date":"2022-05-06","current":-7.934642,"twenty":-55.003842,"median":-42.089758,"eighty":-27.620703,"marketCap":982514932},{"date":"2022-05-13","current":-7.267865,"twenty":-54.946251,"median":-41.906186,"eighty":-27.280132,"marketCap":899950652},{"date":"2022-05-20","current":-6.163516,"twenty":-54.905754,"median":-41.694372,"eighty":-27.026289,"marketCap":763203563},{"date":"2022-05-27","current":-6.271867,"twenty":-54.823551,"median":-41.430782,"eighty":-26.775569,"marketCap":776620258},{"date":"2022-06-03","current":-6.442729,"twenty":-54.717338,"median":-41.342758,"eighty":-26.099247,"marketCap":797777355},{"date":"2022-06-10","current":-6.209357,"twenty":-54.557652,"median":-41.120121,"eighty":-25.818576,"marketCap":768879857},{"date":"2022-06-17","current":-6.571917,"twenty":-54.511693,"median":-40.89219,"eighty":-25.245293,"marketCap":813774184},{"date":"2022-06-24","current":-8.388883,"twenty":-54.40698,"median":-40.800208,"eighty":-25.002486,"marketCap":1038761847},{"date":"2022-07-01","current":-8.793116,"twenty":-54.382983,"median":-40.668026,"eighty":-24.716595,"marketCap":1088816442},{"date":"2022-07-08","current":-10.985145,"twenty":-54.363863,"median":-40.651043,"eighty":-23.157688,"marketCap":1360246513},{"date":"2022-07-15","current":-9.680763,"twenty":-54.250803,"median":-40.300689,"eighty":-21.912481,"marketCap":1198730140},{"date":"2022-07-22","current":-9.047325,"twenty":-53.993365,"median":-40.141071,"eighty":-21.396942,"marketCap":1120294074},{"date":"2022-07-29","current":-9.18068,"twenty":-53.858983,"median":-39.89482,"eighty":-20.83088,"marketCap":1136806930},{"date":"2022-08-05","current":-12.989642,"twenty":-53.679227,"median":-39.157098,"eighty":-20.482375,"marketCap":1608455379},{"date":"2022-08-12","current":-12.493565,"twenty":-53.411973,"median":-38.789003,"eighty":-19.900847,"marketCap":1741890302},{"date":"2022-08-19","current":-11.838735,"twenty":-53.337979,"median":-38.465388,"eighty":-19.728657,"marketCap":1650591936},{"date":"2022-08-26","current":-12.117757,"twenty":-53.305752,"median":-38.163943,"eighty":-19.253329,"marketCap":1689493966},{"date":"2022-09-02","current":-10.712799,"twenty":-53.124249,"median":-37.899038,"eighty":-18.792437,"marketCap":1493610607},{"date":"2022-09-09","current":-11.456778,"twenty":-53.075383,"median":-37.802616,"eighty":-18.455274,"marketCap":1597338383},{"date":"2022-09-16","current":-10.113974,"twenty":-53.00383,"median":-37.690264,"eighty":-18.059341,"marketCap":1410120528},{"date":"2022-09-23","current":-8.466696,"twenty":-52.853783,"median":-37.393272,"eighty":-17.438079,"marketCap":1180452113},{"date":"2022-09-30","current":-8.497924,"twenty":-52.783961,"median":-37.338809,"eighty":-16.517073,"marketCap":1184806017},{"date":"2022-10-07","current":-7.928012,"twenty":-52.663514,"median":-36.555091,"eighty":-13.054653,"marketCap":1105347276},{"date":"2022-10-14","current":-8.587704,"twenty":-52.572763,"median":-36.180368,"eighty":-12.555718,"marketCap":1197323490},{"date":"2022-10-21","current":-9.758755,"twenty":-52.555311,"median":-36.074274,"eighty":-11.951943,"marketCap":1360594875},{"date":"2022-10-28","current":-11.706602,"twenty":-52.454088,"median":-35.903918,"eighty":-11.606672,"marketCap":1632169612},{"date":"2022-11-04","current":-10.95052,"twenty":-52.280562,"median":-35.713709,"eighty":-11.366217,"marketCap":1684660854},{"date":"2022-11-11","current":-10.961165,"twenty":-52.141445,"median":-35.525233,"eighty":-11.186385,"marketCap":1686298568},{"date":"2022-11-18","current":-10.233733,"twenty":-52.033077,"median":-35.425245,"eighty":-11.029695,"marketCap":1574388174},{"date":"2022-11-25","current":-9.854049,"twenty":-51.965429,"median":-35.127475,"eighty":-10.972797,"marketCap":1515976407},{"date":"2022-12-02","current":-10.922132,"twenty":-51.872694,"median":-35.050913,"eighty":-10.933487,"marketCap":1680293620},{"date":"2022-12-09","current":-9.190488,"twenty":-51.760368,"median":-34.976191,"eighty":-10.762271,"marketCap":1413892292},{"date":"2022-12-16","current":-10.027923,"twenty":-51.690661,"median":-34.886786,"eighty":-10.631224,"marketCap":1542725721},{"date":"2022-12-23","current":-9.396298,"twenty":-51.643683,"median":-34.761773,"eighty":-10.461765,"marketCap":1445554745},{"date":"2022-12-30","current":-8.856934,"twenty":-51.58372,"median":-34.61629,"eighty":-10.350133,"marketCap":1362577282},{"date":"2023-01-06","current":-9.697917,"twenty":-51.379038,"median":-34.469384,"eighty":-10.297605,"marketCap":1491956615},{"date":"2023-01-13","current":-12.25635,"twenty":-51.256873,"median":-34.303957,"eighty":-10.297605,"marketCap":1885553659},{"date":"2023-01-20","current":-12.419579,"twenty":-51.251155,"median":-34.181877,"eighty":-10.303283,"marketCap":1910665260},{"date":"2023-01-27","current":-13.076042,"twenty":-51.153931,"median":-33.917788,"eighty":-10.324573,"marketCap":2011657566},{"date":"2023-02-03","current":-13.182496,"twenty":-51.098859,"median":-33.526965,"eighty":-10.344455,"marketCap":2028034697},{"date":"2023-02-10","current":-11.780858,"twenty":-51.090271,"median":-32.866801,"eighty":-10.35598,"marketCap":1812402475},{"date":"2023-02-17","current":-11.947635,"twenty":-51.021067,"median":-32.298777,"eighty":-10.366287,"marketCap":1838059980},{"date":"2023-02-24","current":-11.157115,"twenty":-50.808509,"median":-31.070369,"eighty":-10.408947,"marketCap":1727210659},{"date":"2023-03-03","current":-11.639431,"twenty":-50.542187,"median":-30.891255,"eighty":-10.455157,"marketCap":1801877108},{"date":"2023-03-10","current":-10.49393,"twenty":-50.361636,"median":-30.284071,"eighty":-10.48353,"marketCap":1624544291},{"date":"2023-03-17","current":-11.008164,"twenty":-50.140894,"median":-29.544301,"eighty":-10.497824,"marketCap":1704151903},{"date":"2023-03-24","current":-10.401722,"twenty":-50.020892,"median":-29.090731,"eighty":-10.455157,"marketCap":1610269823},{"date":"2023-03-31","current":-10.508116,"twenty":-49.98944,"median":-28.999526,"eighty":-10.388384,"marketCap":1626740363},{"date":"2023-04-06","current":-10.586137,"twenty":-49.949709,"median":-28.985983,"eighty":-10.415431,"marketCap":1638818759},{"date":"2023-04-14","current":-11.841579,"twenty":-49.849014,"median":-28.581203,"eighty":-10.448769,"marketCap":1833171135},{"date":"2023-04-21","current":-12.008262,"twenty":-49.732136,"median":-28.390444,"eighty":-10.474075,"marketCap":1858974981},{"date":"2023-04-28","current":-11.157632,"twenty":-49.657868,"median":-28.116374,"eighty":-10.487547,"marketCap":1727290638},{"date":"2023-05-05","current":-9.075289,"twenty":-49.553375,"median":-27.841432,"eighty":-10.487547,"marketCap":1443442877},{"date":"2023-05-12","current":-9.718931,"twenty":-49.490296,"median":-27.737946,"eighty":-10.381714,"marketCap":1545815421},{"date":"2023-05-19","current":-10.225916,"twenty":-49.450579,"median":-27.590189,"eighty":-10.319099,"marketCap":1626452351},{"date":"2023-05-26","current":-9.987943,"twenty":-49.384446,"median":-27.302611,"eighty":-10.268406,"marketCap":1588602363},{"date":"2023-06-02","current":-10.139694,"twenty":-49.354964,"median":-27.236588,"eighty":-10.236831,"marketCap":1612738587},{"date":"2023-06-08","current":-8.746348,"twenty":-49.319688,"median":-27.124925,"eighty":-10.222467,"marketCap":1391124169},{"date":"2023-06-16","current":-9.543038,"twenty":-49.101536,"median":-26.951745,"eighty":-10.153489,"marketCap":1517839344},{"date":"2023-06-23","current":-8.080715,"twenty":-48.944671,"median":-26.910903,"eighty":-10.113974,"marketCap":1285253915},{"date":"2023-06-30","current":-7.725481,"twenty":-48.714201,"median":-26.678849,"eighty":-10.083132,"marketCap":1228753209},{"date":"2023-07-07","current":-7.642708,"twenty":-48.581174,"median":-26.094071,"eighty":-10.029342,"marketCap":1215587996},{"date":"2023-07-14","current":-7.687543,"twenty":-48.550488,"median":-25.843916,"eighty":-9.996276,"marketCap":1222719153},{"date":"2023-07-21","current":-7.418531,"twenty":-48.452515,"median":-25.736707,"eighty":-9.976784,"marketCap":1179932211},{"date":"2023-07-28","current":-7.642708,"twenty":-48.322595,"median":-25.297621,"eighty":-9.91863,"marketCap":1215587996},{"date":"2023-08-04","current":-8.325772,"twenty":-48.26907,"median":-25.145432,"eighty":-9.856413,"marketCap":1312091662},{"date":"2023-08-11","current":-7.046225,"twenty":-48.239401,"median":-24.892029,"eighty":-9.804457,"marketCap":1110442734},{"date":"2023-08-18","current":-6.596466,"twenty":-48.152272,"median":-24.716595,"eighty":-9.765337,"marketCap":1039563411},{"date":"2023-08-25","current":-6.746385,"twenty":-48.032791,"median":-23.741966,"eighty":-9.707694,"marketCap":1063189852},{"date":"2023-09-01","current":-6.65225,"twenty":-47.951039,"median":-22.317695,"eighty":-9.667636,"marketCap":1048354644},{"date":"2023-09-08","current":-6.613898,"twenty":-47.924458,"median":-21.936196,"eighty":-9.572037,"marketCap":1042310671},{"date":"2023-09-15","current":-6.756845,"twenty":-47.90723,"median":-21.639761,"eighty":-9.529071,"marketCap":1064838208},{"date":"2023-09-22","current":-6.056058,"twenty":-47.860111,"median":-21.384569,"eighty":-9.413184,"marketCap":954398332},{"date":"2023-09-29","current":-4.985701,"twenty":-47.781558,"median":-20.887073,"eighty":-9.333925,"marketCap":785716531},{"date":"2023-10-06","current":-5.484271,"twenty":-47.716741,"median":-20.688591,"eighty":-9.24394,"marketCap":864288184},{"date":"2023-10-13","current":-4.351157,"twenty":-47.625158,"median":-20.459176,"eighty":-9.174333,"marketCap":685716245},{"date":"2023-10-20","current":-4.145453,"twenty":-47.489734,"median":-20.157585,"eighty":-9.106984,"marketCap":653298570},{"date":"2023-10-27","current":-4.012966,"twenty":-47.294195,"median":-19.910127,"eighty":-9.072011,"marketCap":632419390},{"date":"2023-11-03","current":-3.963586,"twenty":-47.080481,"median":-19.830218,"eighty":-8.938402,"marketCap":663738160},{"date":"2023-11-10","current":-4.696304,"twenty":-47.063128,"median":-19.683289,"eighty":-8.857001,"marketCap":786438288},{"date":"2023-11-17","current":-5.904393,"twenty":-46.987256,"median":-19.373965,"eighty":-8.803369,"marketCap":988743705},{"date":"2023-11-24","current":-6.540402,"twenty":-46.919749,"median":-19.080109,"eighty":-8.726901,"marketCap":1095249134},{"date":"2023-12-01","current":-6.805952,"twenty":-46.878192,"median":-18.817183,"eighty":-8.686608,"marketCap":1139717896},{"date":"2023-12-08","current":-7.763244,"twenty":-46.855589,"median":-18.510438,"eighty":-8.598634,"marketCap":1300025038},{"date":"2023-12-15","current":-8.34352,"twenty":-46.846723,"median":-18.368664,"eighty":-8.460015,"marketCap":1397197517},{"date":"2023-12-22","current":-8.294344,"twenty":-46.816053,"median":-18.030986,"eighty":-8.361665,"marketCap":1388962561},{"date":"2023-12-29","current":-8.79266,"twenty":-46.777903,"median":-17.79126,"eighty":-8.388883,"marketCap":1472410114},{"date":"2024-01-05","current":-8.923796,"twenty":-46.766793,"median":-17.452275,"eighty":-8.343329,"marketCap":1494369997},{"date":"2024-01-12","current":-9.674507,"twenty":-46.627671,"median":-17.043728,"eighty":-8.370738,"marketCap":1620083291},{"date":"2024-01-19","current":-9.548135,"twenty":-46.523894,"median":-16.749871,"eighty":-8.403522,"marketCap":1598921100},{"date":"2024-01-26","current":-11.176934,"twenty":-46.396169,"median":-14.953625,"eighty":-8.429475,"marketCap":1871678229},{"date":"2024-02-02","current":-11.471803,"twenty":-46.233294,"median":-13.281852,"eighty":-8.443505,"marketCap":1921056675},{"date":"2024-02-09","current":-11.928148,"twenty":-46.219098,"median":-13.205561,"eighty":-8.460015,"marketCap":1997475698},{"date":"2024-02-16","current":-13.135706,"twenty":-46.203228,"median":-13.097993,"eighty":-8.479187,"marketCap":2199692190},{"date":"2024-02-23","current":-16.837086,"twenty":-46.159109,"median":-13.182496,"eighty":-8.497945,"marketCap":2474411842},{"date":"2024-03-01","current":-17.756077,"twenty":-46.044123,"median":-13.272981,"eighty":-8.508435,"marketCap":2609468650},{"date":"2024-03-08","current":-17.756077,"twenty":-46.020308,"median":-13.374413,"eighty":-8.557588,"marketCap":2609468650},{"date":"2024-03-15","current":-16.42957,"twenty":-45.949772,"median":-13.662373,"eighty":-8.593169,"marketCap":2414522397},{"date":"2024-03-22","current":-16.974311,"twenty":-45.822699,"median":-16.167875,"eighty":-8.619808,"marketCap":2494578695},{"date":"2024-03-28","current":-16.704019,"twenty":-45.761534,"median":-16.421253,"eighty":-8.638924,"marketCap":2454856105},{"date":"2024-04-05","current":-15.069795,"twenty":-45.711642,"median":-16.371353,"eighty":-8.670473,"marketCap":2214687210},{"date":"2024-04-12","current":-15.473153,"twenty":-45.704713,"median":-16.157001,"eighty":-8.686608,"marketCap":2273965538},{"date":"2024-04-19","current":-14.604062,"twenty":-45.657644,"median":-15.55632,"eighty":-8.686608,"marketCap":2146242131},{"date":"2024-04-26","current":-13.923994,"twenty":-45.5064,"median":-15.136328,"eighty":-8.687717,"marketCap":2046298037},{"date":"2024-05-03","current":-14.407727,"twenty":-45.384235,"median":-14.959599,"eighty":-8.704809,"marketCap":2227304910},{"date":"2024-05-10","current":-15.324582,"twenty":-45.271672,"median":-15.123853,"eighty":-8.713937,"marketCap":2369042495},{"date":"2024-05-17","current":-14.129892,"twenty":-45.224602,"median":-15.056286,"eighty":-8.746348,"marketCap":2184354127},{"date":"2024-05-24","current":-13.590098,"twenty":-45.023652,"median":-14.844325,"eighty":-8.77228,"marketCap":2100906890},{"date":"2024-05-31","current":-12.744686,"twenty":-44.975332,"median":-14.700565,"eighty":-8.788584,"marketCap":1970213792},{"date":"2024-06-07","current":-13.082057,"twenty":-44.925971,"median":-14.537498,"eighty":-8.793025,"marketCap":2022368315},{"date":"2024-06-14","current":-13.213037,"twenty":-44.906953,"median":-14.383912,"eighty":-8.797997,"marketCap":2042616541},{"date":"2024-06-21","current":-12.697057,"twenty":-44.90384,"median":-14.292624,"eighty":-8.805809,"marketCap":1962850801},{"date":"2024-06-28","current":-11.847676,"twenty":-44.881476,"median":-14.217211,"eighty":-8.812693,"marketCap":1831544120},{"date":"2024-07-05","current":-12.006439,"twenty":-44.829216,"median":-14.127873,"eighty":-8.814742,"marketCap":1856087425},{"date":"2024-07-12","current":-16.789169,"twenty":-44.745164,"median":-14.169583,"eighty":-8.831969,"marketCap":2595454482},{"date":"2024-07-19","current":-17.106695,"twenty":-44.652302,"median":-14.288247,"eighty":-8.856979,"marketCap":2644541092},{"date":"2024-07-26","current":-17.678241,"twenty":-44.511281,"median":-14.383912,"eighty":-8.863292,"marketCap":2732896989},{"date":"2024-08-02","current":-16.685974,"twenty":-44.415386,"median":-14.439331,"eighty":-8.882836,"marketCap":2579501334},{"date":"2024-08-09","current":-16.211527,"twenty":-44.384878,"median":-14.691387,"eighty":-8.906376,"marketCap":2559054389},{"date":"2024-08-16","current":-17.13477,"twenty":-44.303137,"median":-14.819835,"eighty":-8.920794,"marketCap":2704792043},{"date":"2024-08-23","current":-19.297835,"twenty":-44.240444,"median":-15.042778,"eighty":-8.934868,"marketCap":3046240465},{"date":"2024-08-30","current":-19.532091,"twenty":-44.22788,"median":-15.130091,"eighty":-8.97565,"marketCap":3083218688},{"date":"2024-09-06","current":-18.336578,"twenty":-44.194716,"median":-15.213448,"eighty":-9.018995,"marketCap":2894502242},{"date":"2024-09-13","current":-18.611223,"twenty":-44.032244,"median":-15.280922,"eighty":-9.051279,"marketCap":2937856020},{"date":"2024-09-20","current":-20.109653,"twenty":-43.886709,"median":-15.45652,"eighty":-9.068733,"marketCap":3174389133},{"date":"2024-09-27","current":-19.665374,"twenty":-43.807738,"median":-15.639486,"eighty":-9.079877,"marketCap":3104258021},{"date":"2024-10-04","current":-17.391477,"twenty":-43.585821,"median":-15.656,"eighty":-9.106984,"marketCap":2745314241},{"date":"2024-10-11","current":-18.1831,"twenty":-43.426785,"median":-16.157001,"eighty":-9.143183,"marketCap":2870275131},{"date":"2024-10-18","current":-18.744507,"twenty":-43.269622,"median":-16.281044,"eighty":-9.152191,"marketCap":2958895353},{"date":"2024-10-25","current":-19.382652,"twenty":-43.188613,"median":-16.421253,"eighty":-9.17001,"marketCap":3059629132},{"date":"2024-11-01","current":-17.970803,"twenty":-42.953958,"median":-16.432042,"eighty":-9.174333,"marketCap":3009642282},{"date":"2024-11-08","current":-19.703301,"twenty":-42.897474,"median":-16.45452,"eighty":-9.181514,"marketCap":3299790710},{"date":"2024-11-15","current":-16.226703,"twenty":-42.824045,"median":-16.632072,"eighty":-9.185976,"marketCap":2717550897},{"date":"2024-11-22","current":-17.394593,"twenty":-42.641415,"median":-16.63794,"eighty":-9.198528,"marketCap":2913142024},{"date":"2024-11-29","current":-18.117756,"twenty":-42.362762,"median":-16.704019,"eighty":-9.230689,"marketCap":3034253086},{"date":"2024-12-06","current":-18.048147,"twenty":-42.117999,"median":-16.760212,"eighty":-9.274328,"marketCap":3022595337},{"date":"2024-12-13","current":-16.292445,"twenty":-42.089758,"median":-16.770553,"eighty":-9.296942,"marketCap":2728560993},{"date":"2024-12-20","current":-15.723969,"twenty":-42.026009,"median":-16.710256,"eighty":-9.297366,"marketCap":2633356040},{"date":"2024-12-27","current":-15.511274,"twenty":-41.948978,"median":-16.669034,"eighty":-9.299865,"marketCap":2597735140},{"date":"2025-01-03","current":-16.083617,"twenty":-41.901479,"median":-16.632072,"eighty":-9.317721,"marketCap":2693587745},{"date":"2025-01-10","current":-14.761041,"twenty":-41.841229,"median":-16.510768,"eighty":-9.338641,"marketCap":2472090508},{"date":"2025-01-17","current":-15.704633,"twenty":-41.745207,"median":-16.439891,"eighty":-9.354352,"marketCap":2630117777},{"date":"2025-01-24","current":-17.154827,"twenty":-41.651541,"median":-16.567015,"eighty":-9.358228,"marketCap":2872987554},{"date":"2025-01-31","current":-15.310181,"twenty":-41.477861,"median":-16.437202,"eighty":-9.370749,"marketCap":2564057197},{"date":"2025-02-07","current":-14.43233,"twenty":-41.453375,"median":-16.425411,"eighty":-9.413184,"marketCap":2417040025},{"date":"2025-02-14","current":-14.262174,"twenty":-41.388207,"median":-16.396436,"eighty":-9.48073,"marketCap":2388543305},{"date":"2025-02-21","current":-14.235104,"twenty":-41.36853,"median":-16.354374,"eighty":-9.48073,"marketCap":2384009735},{"date":"2025-02-28","current":-9.095045,"twenty":-41.316985,"median":-16.292445,"eighty":-9.48073,"marketCap":2035998663},{"date":"2025-03-07","current":-9.54182,"twenty":-41.252803,"median":-16.219115,"eighty":-9.364362,"marketCap":2136012633},{"date":"2025-03-14","current":-9.971187,"twenty":-41.120121,"median":-16.157001,"eighty":-9.396298,"marketCap":2232129954},{"date":"2025-03-21","current":-9.44028,"twenty":-41.064375,"median":-15.882524,"eighty":-9.44028,"marketCap":2113282185},{"date":"2025-03-28","current":-8.59315,"twenty":-40.921429,"median":-15.785844,"eighty":-9.356694,"marketCap":1923645308},{"date":"2025-04-04","current":-6.402796,"twenty":-40.862951,"median":-15.746717,"eighty":-9.297366,"marketCap":1433317081},{"date":"2025-04-11","current":-6.997528,"twenty":-40.836961,"median":-15.704633,"eighty":-9.230689,"marketCap":1566452560},{"date":"2025-04-17","current":-7.534237,"twenty":-40.778157,"median":-15.657984,"eighty":-9.184014,"marketCap":1686599211},{"date":"2025-04-25","current":-9.649161,"twenty":-40.687293,"median":-15.64736,"eighty":-9.172062,"marketCap":2160041963},{"date":"2025-05-02","current":-10.262501,"twenty":-40.668071,"median":-15.580884,"eighty":-9.179093,"marketCap":2297342930},{"date":"2025-05-09","current":-8.129065,"twenty":-40.65763,"median":-15.513208,"eighty":-9.146726,"marketCap":1958145409},{"date":"2025-05-16","current":-8.177726,"twenty":-40.651841,"median":-15.473153,"eighty":-9.07365,"marketCap":1969866932},{"date":"2025-05-23","current":-8.156099,"twenty":-40.649035,"median":-15.377323,"eighty":-8.951301,"marketCap":1964657366},{"date":"2025-05-30","current":-8.177726,"twenty":-40.441912,"median":-15.295552,"eighty":-8.913864,"marketCap":1969866932},{"date":"2025-06-06","current":-12.884311,"twenty":-40.299994,"median":-15.236704,"eighty":-8.913864,"marketCap":3103598610},{"date":"2025-06-13","current":-12.784286,"twenty":-40.274094,"median":-15.203654,"eighty":-8.921794,"marketCap":3079504370},{"date":"2025-06-20","current":-12.554499,"twenty":-40.211637,"median":-15.136243,"eighty":-8.934518,"marketCap":3024152737},{"date":"2025-06-27","current":-12.357152,"twenty":-40.138734,"median":-15.10522,"eighty":-8.95095,"marketCap":2976615453},{"date":"2025-07-03","current":-13.046424,"twenty":-40.100141,"median":-15.069795,"eighty":-8.963563,"marketCap":3142648605},{"date":"2025-07-11","current":-13.168761,"twenty":-39.933805,"median":-14.938931,"eighty":-9.018995,"marketCap":3172117514},{"date":"2025-07-18","current":-13.50082,"twenty":-39.812951,"median":-14.849403,"eighty":-9.051279,"marketCap":3252104551},{"date":"2025-07-25","current":-13.35518,"twenty":-39.627721,"median":-14.778193,"eighty":-9.068733,"marketCap":3217022517},{"date":"2025-08-01","current":-12.743493,"twenty":-39.147269,"median":-14.691387,"eighty":-9.07924,"marketCap":3069677975},{"date":"2025-08-08","current":-11.898781,"twenty":-39.064709,"median":-14.515474,"eighty":-9.095682,"marketCap":2866202177},{"date":"2025-08-15","current":-10.785615,"twenty":-38.850637,"median":-14.43233,"eighty":-9.106984,"marketCap":2970725155},{"date":"2025-08-22","current":-11.05558,"twenty":-38.768458,"median":-14.383912,"eighty":-9.124493,"marketCap":3045082656},{"date":"2025-08-29","current":-10.837532,"twenty":-38.768458,"median":-14.26484,"eighty":-9.124493,"marketCap":2985024674},{"date":"2025-09-05","current":-10.954343,"twenty":-38.809548,"median":-14.147693,"eighty":-9.115738,"marketCap":3017198593},{"date":"2025-09-12","current":-11.99267,"twenty":-38.768458,"median":-14.036722,"eighty":-9.124493,"marketCap":3303188981},{"date":"2025-09-19","current":-13.280194,"twenty":-38.768458,"median":-13.923994,"eighty":-9.124493,"marketCap":3657817062},{"date":"2025-09-26","current":-13.948617,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":3841923374},{"date":"2025-10-03","current":-14.536569,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4003865432},{"date":"2025-10-10","current":-14.801343,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4076792980},{"date":"2025-10-17","current":-15.694303,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4322744714},{"date":"2025-10-24","current":-14.993433,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4129701202},{"date":"2025-10-31","current":-15.948693,"twenty":-38.768458,"median":-13.732985,"eighty":-9.124493,"marketCap":4392812359},{"date":"2025-11-07","current":-14.871445,"twenty":-38.510575,"median":-13.732985,"eighty":-9.124493,"marketCap":4388890647},{"date":"2025-11-14","current":-15.512624,"twenty":-37.938352,"median":-13.732985,"eighty":-9.124493,"marketCap":4578116588},{"date":"2025-11-21","current":-15.756418,"twenty":-37.652889,"median":-13.732985,"eighty":-9.124493,"marketCap":4650065615},{"date":"2025-11-28","current":-16.548749,"twenty":-37.32898,"median":-13.732985,"eighty":-9.124493,"marketCap":4883899952},{"date":"2025-12-05","current":-16.146489,"twenty":-36.08467,"median":-13.732985,"eighty":-9.124493,"marketCap":4765184058},{"date":"2025-12-12","current":-23.802748,"twenty":-35.592065,"median":-13.732985,"eighty":-9.124493,"marketCap":7024714560},{"date":"2025-12-19","current":-21.585387,"twenty":-35.069756,"median":-13.732985,"eighty":-9.124493,"marketCap":6370322520},{"date":"2025-12-26","current":-22.534135,"twenty":-34.960597,"median":-13.732985,"eighty":-9.124493,"marketCap":6650319114},{"date":"2026-01-02","current":-21.092037,"twenty":-34.674483,"median":-13.732985,"eighty":-9.124493,"marketCap":6224724290},{"date":"2026-01-09","current":-20.324906,"twenty":-33.447973,"median":-13.732985,"eighty":-9.124493,"marketCap":5998327044},{"date":"2026-01-16","current":-19.278572,"twenty":-29.680357,"median":-13.732985,"eighty":-9.124493,"marketCap":5689530800},{"date":"2026-01-23","current":-19.725839,"twenty":-27.736646,"median":-13.732985,"eighty":-9.124493,"marketCap":5821529194},{"date":"2026-01-30","current":-20.03486,"twenty":-26.936151,"median":-13.732985,"eighty":-9.124493,"marketCap":5912728085},{"date":"2026-02-06","current":-20.585135,"twenty":-25.879653,"median":-13.732985,"eighty":-9.124493,"marketCap":6075126110},{"date":"2026-02-13","current":-22.775389,"twenty":-25.350754,"median":-13.732985,"eighty":-9.124493,"marketCap":6721518248},{"date":"2026-02-20","current":-23.447645,"twenty":-24.971298,"median":-13.732985,"eighty":-9.124493,"marketCap":6919915835},{"date":"2026-02-27","current":-24.821424,"twenty":-24.616503,"median":-13.732985,"eighty":-9.124493,"marketCap":7728175245},{"date":"2026-03-06","current":-21.900597,"twenty":-23.960592,"median":-13.732985,"eighty":-9.124493,"marketCap":6818772746},{"date":"2026-03-13","current":-20.322034,"twenty":-23.398123,"median":-13.732985,"eighty":-9.124493,"marketCap":6327285535},{"date":"2026-03-20","current":-20.864829,"twenty":-22.914822,"median":-13.732985,"eighty":-9.124493,"marketCap":6496285290},{"date":"2026-03-27","current":-21.024783,"twenty":-22.604919,"median":-13.732985,"eighty":-9.124493,"marketCap":6546087150},{"date":"2026-04-02","current":-22.270327,"twenty":-22.323196,"median":-13.732985,"eighty":-9.124493,"marketCap":6933888522}],"updateTime":1775474982200},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYMR\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589359780","title":"BUZZ-U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix","url":"https://stock-news.laohu8.com/highlight/detail?id=2589359780","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589359780?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:34","pubTimestamp":1765204451,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular TherapeutixEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL6N3XE0MO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","LU0661504455.SGD","BK4539","RIO.UK","CVNA","NEE","OCUL","EOG","INCY","IBM","DYN","ALB","FANG","MU","AR","USCB","TSYW.SI","COMP","ACLX","LEN","FCX","CFLT","WYNN","COP","KYMR","WVE","MMM","CRH","GPCR","LU1261432733.SGD","HUT","RIOT","JEF","GM","RIO.AU","FULC","SCCO","BHP.AU","APA"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2589359215","title":"Kymera Therapeutics Shares up 37.9% After Positive Data for Eczema Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2589359215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589359215?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:33","pubTimestamp":1765204380,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"131f4a8ae97812e1f16587f8e011d27b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nFWN3XE13C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589057356","title":"Sector Update: Health Care Stocks Rise Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2589057356","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589057356?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:16","pubTimestamp":1765203384,"startTime":"0","endTime":"0","summary":"Health care stocks were rising pre-bell Monday, with the iShares Biotechnology ETF  0.7% higher and the Health Care Select Sector SPDR Fund  up 0.1%.Kymera Therapeutics  shares were up more than 38% after the company said a phase 1b clinical trial of KT-62 to treat atopic dermatitis demonstrated \"robust clinical activity\" that was seen in all disease endpoints.Arcellx  shares were up more than 13% after the company said results of a phase 2 study of anitocabtagene autoleucel, or anito-cel, in patients with relapsed or refractory multiple myeloma showed a 96% overall response rate.BioNTech  stock was up more than 3% after the company and OncoC4 said their experimental therapy, gotistobart, showed a \"meaningful\" overall survival benefit in certain metastatic squamous non-small cell lung cancer patients during the non-pivotal stage of the global phase 3 trial.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4568","BK4535","XLV","BK4585","BNTX","XBI","BK4581","IBB","ACLX","BK4139","BK4588","BK4551","BK4548","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589564933","title":"Kymera Therapeutics Showcases Advances in Oral Immunology Medicines and Targeted Protein Degradation","url":"https://stock-news.laohu8.com/highlight/detail?id=2589564933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589564933?lang=en_us&edition=fundamental","pubTime":"2025-12-08 22:08","pubTimestamp":1765202881,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics Inc. has released a corporate presentation outlining its advancements in the field of immunology through the development of oral medicines utilizing targeted protein degradation  technology. The company highlights its industry-leading capabilities in hit finding and optimization of oral degraders, with a focus on traditionally undrugged targets within validated pathways. Kymera reports having delivered more than nine development candidates, including four transcription factors in the past five years, and has advanced five new investigational degrader drugs into the clinic since 2020. To date, over 400 healthy volunteers and patients have been dosed across its clinical pipeline, demonstrating over 90% target degradation with favorable tolerability and strong clinical activity. The company states it has approximately $979 million in cash and equivalents, providing a financial runway into the second half of 2028. You can access the full presentation through the link be","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL8G7RL9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589353137","title":"Kymera Therapeutics Shares Gain 32% Premarket After Positive Data for Its Eczema Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2589353137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589353137?lang=en_us&edition=fundamental","pubTime":"2025-12-08 21:10","pubTimestamp":1765199423,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"131f4a8ae97812e1f16587f8e011d27b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL4N3XE0Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589984358","title":"Kymera Therapeutics Stock Soars 30%. Why Investors Are Excited About Its Anti-Inflammatory Drug. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2589984358","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589984358?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:42","pubTimestamp":1765197720,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics stock surged Monday after the biopharmaceutical company released \"positive results\" from a clinical trial evaluating the efficacy of its anti-inflammatory drug candidate.Shares jumped 30% in premarket trading to $86.61 after the drugmaker posted results from a Phase 1b trial for KT-621, its once-a-day oral medication. Researchers are probing its efficacy in patients with Type 2 inflammatory diseases, which are triggered by an overactive immune response. KT-621 works by targeting STAT6, a transcription factor protein that drives immune responses such as allergic reactions.Kymera noted that KT-621 \"achieved deep STAT6 degradation\" across both the 100 mg and 200 mg dose groups, with median reductions of 94% and 98% in skin and blood, respectively. Patients with asthma, a comorbid disease that frequently occurs along with atopic dermatitis, showed a median 56% reduction in fractional exhaled nitric oxide, a measure of airway inflammation.In all, the trial showed \"robust","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ISBC","KYMR","BK4211","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589435867","title":"BRIEF-Kymera Therapeutics Says KT-621 Well-Tolerated With No Serious Adverse Events Reported","url":"https://stock-news.laohu8.com/highlight/detail?id=2589435867","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589435867?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:41","pubTimestamp":1765197671,"startTime":"0","endTime":"0","summary":"BRIEF-Kymera Therapeutics Says KT-621 Well-Tolerated With No Serious Adverse Events ReportedDec 8 (Reuters) - Kymera Therapeutics Inc KYMR.O:KYMERA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM BROADEN","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA7FBLBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589302183","title":"Kymera Therapeutics Stock Surges 23% After Positive Data for Eczema Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2589302183","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589302183?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:32","pubTimestamp":1765197178,"startTime":"0","endTime":"0","summary":"Shares of Kymera Therapeutics KYMR.O rise 23% to $81.98 premarket. KYMR says its experimental oral treatment for eczema eased symptoms and itching in a small early-stage study, while also helping...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"131f4a8ae97812e1f16587f8e011d27b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL6N3XE0P9:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Kymera Therapeutics Stock Surges After Positive Data for Eczema Drug","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2589337267","title":"Kymera Therapeutics Reports Positive Phase 1b Results for Oral STAT6 Degrader KT-621 in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337267","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589337267?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195213,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics Inc. announced positive clinical results from the BroADen Phase 1b trial of KT-621, an oral STAT6 degrader, in patients with moderate to severe atopic dermatitis. The study demonstrated deep STAT6 degradation in both 100 mg and 200 mg dose groups, with median reductions of 94% and 98% in skin and blood, respectively. KT-621 also showed significant reductions in Type 2 biomarkers and robust clinical activity across all disease endpoints, including a mean 63% reduction in EASI scores and a mean 40% reduction in peak pruritus NRS. The results were presented on December 8, 2025. The ongoing BROADEN2 Phase 2b trial in atopic dermatitis is expected to report data by mid-2027, and a Phase 2b asthma trial is planned to begin in the first quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"131f4a8ae97812e1f16587f8e011d27b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL9sKjlP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BGHQF748.EUR","KYMR","LU2095319765.USD","IE00B64PRP62.GBP","NDAQ","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210150020.SGD","BK4588","IE00BKPKM429.USD","SG9999014039.USD","BK4112","BK4585","SG9999014021.USD","SG9999014013.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589933081","title":"Kymera Therapeutics Inc - Robust Clinical Activity Was Observed Across All Disease Endpoints Measured for KT-621","url":"https://stock-news.laohu8.com/highlight/detail?id=2589933081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589933081?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"131f4a8ae97812e1f16587f8e011d27b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA7FBLBQ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589372213","title":"Kymera Therapeutics Announces Positive Results From Broaden Phase 1B Clinical Trial of KT-621, a First-in-Class, Oral Stat6 Degrader, in Patients With Moderate to Severe Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2589372213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589372213?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"131f4a8ae97812e1f16587f8e011d27b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA7FBLBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589337050","title":"Kymera Therapeutics Inc - KT-621 Broaden2 Phase 2B Trial to Severe Ad Ongoing, Data Expected by Mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2589337050","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589337050?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA7FBLBQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589330843","title":"Kymera Therapeutics Inc - KT-621 Shows 63% Easi Reduction and 40% Peak Pruritus Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2589330843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589330843?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"131f4a8ae97812e1f16587f8e011d27b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA7FBLBQ:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589308603","title":"Kymera Therapeutics Inc - KT-621 Achieves 94% and 98% Stat6 Degradation in Skin and Blood","url":"https://stock-news.laohu8.com/highlight/detail?id=2589308603","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589308603?lang=en_us&edition=fundamental","pubTime":"2025-12-08 20:00","pubTimestamp":1765195202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"131f4a8ae97812e1f16587f8e011d27b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nTUA7FBLBQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589711817","title":"Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2589711817","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589711817?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:01","pubTimestamp":1764968460,"startTime":"0","endTime":"0","summary":"Company to host video conference call and webcast at 8:00 a.m. ET on Monday, December 8, 2025 WATERTOWN, Mass., Dec.  05, 2025  (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/05/3200970/0/en/Kymera-Therapeutics-to-Announce-KT-621-BroADen-Phase-1b-Atopic-Dermatitis-Trial-Results-on-December-8-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","LU0541501648.USD","LU1829250122.USD","LU1162221912.USD","LU0072461881.USD","BK4201","LU0162691827.USD","KYMR","BK4096","LU0320765646.SGD","LU0541502299.USD","PN","BK4585","BK4115","BP","AD","KT","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588705090","title":"A Look at Kymera Therapeutics (KYMR) Valuation Following BROADEN2 Phase 2b KT-621 Dosing Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2588705090","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588705090?lang=en_us&edition=fundamental","pubTime":"2025-12-04 11:25","pubTimestamp":1764818749,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics (KYMR) just kicked off dosing in its BROADEN2 Phase 2b trial for KT-621 in moderate to severe atopic dermatitis, a milestone that helps explain the stock’s recent momentum.\nSee our latest analysis for Kymera Therapeutics.\nThe BROADEN2 dosing news lands after a strong run, with a 90 day share price return of 51.67% and a three year total shareholder return of 151.87%, suggesting momentum is clearly building as investors reassess Kymera’s growth potential.\nIf this kind of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kymr/kymera-therapeutics/news/a-look-at-kymera-therapeutics-kymr-valuation-following-broad","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kymr/kymera-therapeutics/news/a-look-at-kymera-therapeutics-kymr-valuation-following-broad","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4115","KYMR","KT","LU0541502299.USD","LU0541501648.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586649372","title":"Kymera Therapeutics Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2586649372","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586649372?lang=en_us&edition=fundamental","pubTime":"2025-11-27 02:14","pubTimestamp":1764180840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYMR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 26, 2025 13:14 ET (18:14 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586254248","title":"Kymera Therapeutics (KYMR) Gets a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2586254248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586254248?lang=en_us&edition=fundamental","pubTime":"2025-11-26 20:36","pubTimestamp":1764160586,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Kymera Therapeutics today and set a price target of $80.00. Devarakonda co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kymera-therapeutics-kymr-gets-a-buy-from-truist-financial-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kymera-therapeutics-kymr-gets-a-buy-from-truist-financial-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYMR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586041470","title":"Truist Securities Raises Price Target on Kymera Therapeutics to $80 From $68, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2586041470","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586041470?lang=en_us&edition=fundamental","pubTime":"2025-11-26 01:28","pubTimestamp":1764091710,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics (KYMR) has an average rating of buy and mean price target of $76.68, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KYMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586427055","title":"Kymera Therapeutics Launches Phase 2b Trial of Oral STAT6 Degrader KT-621 in Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2586427055","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586427055?lang=en_us&edition=fundamental","pubTime":"2025-11-25 20:00","pubTimestamp":1764072023,"startTime":"0","endTime":"0","summary":"Kymera Therapeutics Inc. has announced the initiation of dosing in the BROADEN2 Phase 2b clinical trial evaluating KT-621, an oral STAT6 degrader, in patients with moderate to severe atopic dermatitis. Data from the BROADEN2 trial are expected to be reported by mid-2027. The company also completed dosing in the KT-621 BroADen Phase 1b trial for atopic dermatitis, with results anticipated in December 2025. Additionally, Kymera plans to initiate the BREADTH Phase 2b trial of KT-621 in moderate to severe asthma in the first quarter of 2026. No results from these studies have been presented yet; all are scheduled for future reporting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content use","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL3tZ8T8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","IE00BGHQF748.EUR","LU2095319765.USD","LU2210149790.SGD","LU2210150020.SGD","BK4112","BK4588","BK4139","NDAQ","BK4585","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":159,"code":"91000000","status":"200"}]}}